To investigate this hypothesis, future studies are warranted that examine whether changes in insulin‐stimulated blood flow precede changes in bone structure and biomechanical properties, as well as osteoblast and osteoclast differentiation and activity during the pathogenesis of obesity‐associated T2D. The gene discussed is INS; the disease is Obesity.